BioMimetic Therapeutics Stock Price, News & Analysis (NASDAQ:BMTI)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About BioMimetic Therapeutics (NASDAQ:BMTI)

BioMimetic Therapeutics logoBioMimetic Therapeutics, Inc. is a biotechnology company engaged in developing and commercializing products to the healing of musculoskeletal injuries and diseases, including therapies for orthopedic, sports medicine and spine applications. The Company's Augment platform of product and product candidates include an engineered version of recombinant human platelet-derived growth factor BB (rhPDGF-BB), one of the wound healing and tissue repair stimulators in the body. Its platform regenerative technology for promoting tissue healing and regeneration combines rhPDGF-BB with tissue specific matrices, when appropriate. The matrices are engineered or natural scaffold materials, such as Beta Tri-Calcium Phosphate. The Company's product candidates include Augment Bone Graft (Augment), Augmen Injectable Bone Graft (Augment Injectable) and Augment Rotator Cuff Graft (Augment Rotator Cuff Graft). In March 2013, Wright Medical Group Inc completed acquisition of BioMimetic Therapeutics, Inc.

Receive BMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for BMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

BioMimetic Therapeutics (NASDAQ:BMTI) Frequently Asked Questions

What is BioMimetic Therapeutics' stock symbol?

BioMimetic Therapeutics trades on the NASDAQ under the ticker symbol "BMTI."

Who are some of BioMimetic Therapeutics' key competitors?

How do I buy BioMimetic Therapeutics stock?

Shares of BioMimetic Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact BioMimetic Therapeutics?

BioMimetic Therapeutics' mailing address is 389 Nichol Mill Lane, FRANKLIN, TN 37067, United States. The biotechnology company can be reached via phone at +1-615-8441280.

MarketBeat Community Rating for BioMimetic Therapeutics (BMTI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  40 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  88
MarketBeat's community ratings are surveys of what our community members think about BioMimetic Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BioMimetic Therapeutics (NASDAQ:BMTI) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


BioMimetic Therapeutics (NASDAQ:BMTI) Earnings History and Estimates Chart

Earnings by Quarter for BioMimetic Therapeutics (NASDAQ:BMTI)

BioMimetic Therapeutics (NASDAQ BMTI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/5/2012Q312($0.23)($0.16)ViewN/AView Earnings Details
8/2/2012Q2 2012($0.21)($0.23)ViewN/AView Earnings Details
5/9/2012Q1 2012($0.21)($0.22)ViewN/AView Earnings Details
3/13/2012Q4 2011($0.26)($0.25)ViewN/AView Earnings Details
11/8/2011Q3 2011($0.32)($0.25)ViewN/AView Earnings Details
8/4/2011Q2 2011($0.33)($0.29)ViewN/AView Earnings Details
5/9/2011Q1 2011($0.35)($0.29)ViewN/AView Earnings Details
3/10/2011Q4 2010($0.34)($0.36)ViewN/AView Earnings Details
11/3/2010Q3 2010($0.31)($0.29)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.38)($0.35)ViewN/AView Earnings Details
5/10/2010Q1 2010($0.36)($0.39)ViewN/AView Earnings Details
3/11/2010Q4 2009($0.41)($0.16)ViewN/AView Earnings Details
11/5/2009Q3 2009($0.42)($0.36)ViewN/AView Earnings Details
8/10/2009Q2 2009($0.47)($0.32)ViewN/AView Earnings Details
5/7/2009Q1 2009($0.48)($0.43)ViewN/AView Earnings Details
3/12/2009Q4 2008($0.53)($0.43)ViewN/AView Earnings Details
11/10/2008Q3 2008($0.51)($0.42)ViewN/AView Earnings Details
8/11/2008Q2 2008($0.40)($0.50)ViewN/AView Earnings Details
5/8/2008Q1 2008$1.36$1.62ViewN/AView Earnings Details
3/12/2008Q4 2007($0.31)($0.37)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


BioMimetic Therapeutics (NASDAQ:BMTI) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for BioMimetic Therapeutics (NASDAQ:BMTI)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for BioMimetic Therapeutics (NASDAQ BMTI)

No insider trades for this company have been tracked by


BioMimetic Therapeutics (NASDAQ BMTI) News Headlines

No headlines for this company have been tracked by

SEC Filings

BioMimetic Therapeutics (NASDAQ:BMTI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


BioMimetic Therapeutics (NASDAQ:BMTI) Income Statement, Balance Sheet and Cash Flow Statement


BioMimetic Therapeutics (NASDAQ BMTI) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.